PART I Overview Anteris is a structural heart company dedicated to revolutionizing cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Our lead product, the DurAVR THV System, was designed in collaboration with the worlds leading interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from a narrowing of the aortic valve. The balloon-expandable DurAVR THV i...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001140361-26-006977 | EDGAR | 95K words |
| 2025-03-12 | 2024-12-31 | 0001140361-25-008455 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001140361-25-041643 | EDGAR | 22K words |
| 2025-08-11 | 2025-06-30 | 0001140361-25-030146 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001140361-25-018701 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001140361-26-007568 | EDGAR | 1K words |
| 2026-02-27 | 0001140361-26-007003 | EDGAR | — |
| 2026-01-22 | 0001140361-26-002070 | EDGAR | — |
| 2026-01-22 | 0001140361-26-001938 | EDGAR | — |
| 2025-12-15 | 0001140361-25-045444 | EDGAR | — |
| 2025-12-04 | 0001140361-25-044257 | EDGAR | — |
| 2025-12-01 | 0001140361-25-043801 | EDGAR | — |
| 2025-11-17 | 0001140361-25-042395 | EDGAR | — |
| 2025-11-13 | 0001140361-25-041723 | EDGAR | — |
| 2025-11-03 | 0001140361-25-040087 | EDGAR | — |
45 total filings indexed. 30 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002011514 |
| Ticker | AVR |
| Exchange | Nasdaq |
| SIC | 3842: Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Incorporated | DE |
| Website | https://www.anteristech.com |
| Listed | 2024-12-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report